Medro requires a quarterly prepayment
Use the Medro review to check when payment is collected, what the next quarter costs and how far ahead you must cancel.
Head-to-head · WeighScore
By GLP-1 ScorecardUpdated
Start with Pallas’s four-week plan if you want a shorter commitment. Medro’s introductory offer requires three months paid upfront. Put the initial charge and the first regular renewal side by side before choosing.
Use the Medro review to check when payment is collected, what the next quarter costs and how far ahead you must cancel.
Use the Pallas Health review to separate the first-period discount from the four-week renewal price. Ask for the full amount due if you select the annual option.
Compare the same medication and supply period. Ask how much you could recover if you stop after a prescription is issued.
Score comparison
Pallas Health has the higher recorded score — 69.3/100 to 63.6/100.
Pallas Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Pallas advertises four-week renewal or an annual option for compounded injections. Ask for the full amount due and confirm when a prescribed order becomes final.
Before comparing the headline prices, the Medro review and the Pallas Health review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Medro vs PauseRX and Options Medical Weight Loss vs Pallas Health compare each of them with another graded program, and the list of alternatives to Medro ranks the programs closest to Medro on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the PlexusDx review covers one graded close to these two, at 67.7/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
Swipe or scroll to compare both providers.
| Metric | Medro | Pallas Health |
|---|---|---|
| WeighScore | 63.6/100 | 69.3/100 |
| Grade | C | C |
| Site position | #271 | #142 |
| Semaglutide | From $99/mo equivalent (introductory, quarterly prepay, compounded) | $139 first period, then $199 every four weeks (compounded; confirm selected quote) |
| Tirzepatide | From $199/mo equivalent (introductory, quarterly prepay, compounded) | $179 first period, then $299 every four weeks (compounded; confirm selected quote) |
| Coverage | All 50 states | Confirm treatment and visit requirements for your state |
| Brand-name access | Not confirmed | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
What to consider
Strengths
What to consider
Featured provider
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.